00968nam0 2200289 450 991034124210332120191023113024.0978-88-15-28397-920191023d2019----km y0itay50 baitaIT 001yyÈ possibile una scuola diversa?una ricerca sperimentale per migliorare la qualità scolasticaa cura di Daniele Checchi, Giorgio ChiossoBolognail Mulino2019320 p.fig., tab.22 cmCollana della Fondazione per la scuola della Compagnia di San PaoloIstruzione pubblicaRicercaPiemonte2013-201837122itaChecchi,Daniele<1958- >Chiosso,GiorgioITUNINAREICATUNIMARCBK9910341242103321371 CHE 16565BFSBFSÈ possibile una scuola diversa1565391UNINA04425nam 2200649Ia 450 991014544020332120180612233952.01-281-06941-897866110694140-470-69232-40-470-76651-4(CKB)1000000000402079(EBL)320087(OCoLC)476116586(SSID)ssj0000176875(PQKBManifestationID)11182948(PQKBTitleCode)TC0000176875(PQKBWorkID)10210099(PQKB)10256053(MiAaPQ)EBC320087(EXLCZ)99100000000040207920070829d2007 uy 0engur|n|---|||||txtccrImmune dysfunction and immunotherapy in heart disease[electronic resource] /edited by Ronald Ross Watson & Douglas F. LarsonOxford Blackwell20071 online resource (323 p.)Description based upon print version of record.1-4051-5568-X Includes bibliographical references and index.Immune Dysfunction and Immunotherapy in Heart Disease; Contents; Contributors; Preface; About the Editors; Part I Immune dysfunction leading to heart disease: induction by physiological changes; 1 Immunosuppression by ultraviolet light-B radiation: a mediator of cardiac remodeling; 2 Immune mechanisms in pediatric cardiovascular disease; 3 Heart failure-role of autoimmunity; 4 Immune basis of hypertension in humans; 5 Immune dysregulation: potential mediator metabolic syndrome-induced cardiac remodeling; 6 T helper 2 cell cytokines in remodeling of aortic wall7 Effects of TNF-a on cardiac function8 Immunosuppression in promotion of cardiac allograft vasculopathy; 9 Immunotherapy for left ventricular dysfunction after heart transplantation; Part II Immune dysfunction promoting CVD: induction by transplantation drugs; 10 Immunomodulating therapy in chronic heart failure; 11 Statins in atherosclerosis: role of immune regulation; 12 ACE inhibitors as immunomodulators: treatment of cardiovascular disease; 13 Treatment of heart failure by anticytokine therapiesPart III Immune dysfunction leading to heart dysfunction: induction or prevention by cardiotherapeutic drugs14 Pathogenesis of cardiovascular complications in the acquired immunodeficiency syndrome; 15 Cytokines and T cell-mediated responses in autoimmune myocarditis; 16 Drugs of abuse: accentuation of immunomodulation of viral myocarditis; Part IV Immune dysfunction leading to heart disease: induction by pathogens; 17 Osteopontin: the link between the immune system and cardiac remodeling; 18 Inflammatory immune activation in heart failure patients: therapeutic implications26 Role of oral pathogens in the pathogenesis of coronary heart disease27 Myocardial regenerative potential by stem cell transplant; 28 Bioflavanoids and dietary anti-inflammatory actions: role in cardiovascular diseases; IndexCurrent heart failure therapeutics affects symptoms without appreciably reducing the mortality rate of 50% in five years -- suggesting a failure in treating the underlying mechanism. This book proposes a new mechanism for heart failure; immune mediated cardiac remodelling for cardiac dysfunction. The outstanding editor team of two internationally recognized immunologists -- Ronald Watson, who has studied heart disease in immune dysfunction for a decade and has a patent for an immunotherapy of heart disease by immune regulation, and Douglas Larson, whose experience in cardiac transplantatHeartDiseasesImmunological aspectsHeartDiseasesImmunotherapyImmunologic diseasesComplicationsElectronic books.HeartDiseasesImmunological aspects.HeartDiseasesImmunotherapy.Immunologic diseasesComplications.616.1/207616.1207YB 9022rvkWatson Ronald R(Ronald Ross)872276Larson Douglas F941282MiAaPQMiAaPQMiAaPQBOOK9910145440203321Immune dysfunction and immunotherapy in heart disease2123134UNINA